GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
44.15
+0.46 (1.05%)
At close: Oct 14, 2025, 4:00 PM EDT
44.10
-0.05 (-0.11%)
After-hours: Oct 14, 2025, 7:44 PM EDT
GSK Revenue
GSK had revenue of 7.99B GBP in the quarter ending June 30, 2025, with 1.29% growth. This brings the company's revenue in the last twelve months to 31.63B, up 0.59% year-over-year. In the year 2024, GSK had annual revenue of 31.38B with 3.46% growth.
Revenue (ttm)
31.63B GBP
Revenue Growth
+0.59%
P/S Ratio
2.02
Revenue / Employee
460,898 GBP
Employees
68,629
Market Cap
87.54B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
GSK News
- 4 days ago - GSK: Compelling Value, No Red Flags Ahead Of Earnings, Blenrep FDA Decision Soon - Seeking Alpha
- 5 days ago - GSK's Hidden Growth Engines Beyond HIV And Oncology - Seeking Alpha
- 8 days ago - My Top 5 Biotech Stocks Big Pharma Could Buy Next - Seeking Alpha
- 8 days ago - Focus: US Health Secretary Kennedy speeds autism drug with GSK help - Reuters
- 13 days ago - New Local Data in GSK and IQVIA's Vaccine Track Supports Smarter Public Health Action at the Community Level - Business Wire
- 13 days ago - Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields - Benzinga
- 15 days ago - Emma Walmsley To Step Down As GSK CEO After Nine Years, Luke Miels To Lead Starting January 2026 - Benzinga
- 15 days ago - GSK turns to insider to be next CEO — and the stock rallies - Market Watch